Pharma CEO raises EpiPen price by 400%, and gets a 671% raise

No doubt, the proceeds will go towards patient-advocated reform of Big Pharma.

Meanwhile, there’s this:

Seems to have bi-partisan momentum right now. We’ll see how long that lasts after the election.

1 Like